Business Context and Reporting Period
Company: Clover Health Investments, Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: September 26, 2024
Event: Notification from the SEC Division of Enforcement regarding the conclusion of an investigation.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a report on a regulatory event.
Material Changes
The material change reported is the conclusion of an SEC investigation that commenced in February 2021. The SEC Staff notified the Company that, based on information available as of the notice date, they did not intend to recommend an enforcement action against the Company.
Guidance, Outlook, and Risks
Management Commentary: The Company previously disclosed the investigation in its periodic reports. Further details were referenced in the Form 10-Q for the quarter ended June 30, 2024.
Risks and Contingencies: The risk of an enforcement action related to the 2021 investigation has been resolved as of this notice, though the filing notes the conclusion is based on information available to the SEC at the time of the notice.
Investor Verification Checklist
- Verify the specific scope of the investigation concluded in February 2021 by reviewing prior filings, specifically the Form 10-Q filed on August 8, 2024.
- Confirm that no other pending investigations or regulatory actions exist by reviewing the "Legal Proceedings" section of the most recent 10-K or 10-Q.
- Review the Company's stock price reaction and analyst commentary following the September 26, 2024 announcement.